Cargando…

Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes

In situ gelling drug delivery systems have gained enormous attention over the last decade. They are in a sol-state before administration, and they are capable of forming gels in response to different endogenous stimuli, such as temperature increase, pH change and the presence of ions. Such systems c...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigani, Barbara, Rossi, Silvia, Sandri, Giuseppina, Bonferoni, Maria Cristina, Caramella, Carla M., Ferrari, Franca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559482/
https://www.ncbi.nlm.nih.gov/pubmed/32927595
http://dx.doi.org/10.3390/pharmaceutics12090859
_version_ 1783594870753984512
author Vigani, Barbara
Rossi, Silvia
Sandri, Giuseppina
Bonferoni, Maria Cristina
Caramella, Carla M.
Ferrari, Franca
author_facet Vigani, Barbara
Rossi, Silvia
Sandri, Giuseppina
Bonferoni, Maria Cristina
Caramella, Carla M.
Ferrari, Franca
author_sort Vigani, Barbara
collection PubMed
description In situ gelling drug delivery systems have gained enormous attention over the last decade. They are in a sol-state before administration, and they are capable of forming gels in response to different endogenous stimuli, such as temperature increase, pH change and the presence of ions. Such systems can be administered through different routes, to achieve local or systemic drug delivery and can also be successfully used as vehicles for drug-loaded nano- and microparticles. Natural, synthetic and/or semi-synthetic polymers with in situ gelling behavior can be used alone, or in combination, for the preparation of such systems; the association with mucoadhesive polymers is highly desirable in order to further prolong the residence time at the site of action/absorption. In situ gelling systems include also solid polymeric formulations, generally obtained by freeze-drying, which, after contact with biological fluids, undergo a fast hydration with the formation of a gel able to release the drug loaded in a controlled manner. This review provides an overview of the in situ gelling drug delivery systems developed in the last 10 years for non-parenteral administration routes, such as ocular, nasal, buccal, gastrointestinal, vaginal and intravesical ones, with a special focus on formulation composition, polymer gelation mechanism and in vitro release studies.
format Online
Article
Text
id pubmed-7559482
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75594822020-10-26 Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes Vigani, Barbara Rossi, Silvia Sandri, Giuseppina Bonferoni, Maria Cristina Caramella, Carla M. Ferrari, Franca Pharmaceutics Review In situ gelling drug delivery systems have gained enormous attention over the last decade. They are in a sol-state before administration, and they are capable of forming gels in response to different endogenous stimuli, such as temperature increase, pH change and the presence of ions. Such systems can be administered through different routes, to achieve local or systemic drug delivery and can also be successfully used as vehicles for drug-loaded nano- and microparticles. Natural, synthetic and/or semi-synthetic polymers with in situ gelling behavior can be used alone, or in combination, for the preparation of such systems; the association with mucoadhesive polymers is highly desirable in order to further prolong the residence time at the site of action/absorption. In situ gelling systems include also solid polymeric formulations, generally obtained by freeze-drying, which, after contact with biological fluids, undergo a fast hydration with the formation of a gel able to release the drug loaded in a controlled manner. This review provides an overview of the in situ gelling drug delivery systems developed in the last 10 years for non-parenteral administration routes, such as ocular, nasal, buccal, gastrointestinal, vaginal and intravesical ones, with a special focus on formulation composition, polymer gelation mechanism and in vitro release studies. MDPI 2020-09-10 /pmc/articles/PMC7559482/ /pubmed/32927595 http://dx.doi.org/10.3390/pharmaceutics12090859 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Vigani, Barbara
Rossi, Silvia
Sandri, Giuseppina
Bonferoni, Maria Cristina
Caramella, Carla M.
Ferrari, Franca
Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes
title Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes
title_full Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes
title_fullStr Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes
title_full_unstemmed Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes
title_short Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes
title_sort recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559482/
https://www.ncbi.nlm.nih.gov/pubmed/32927595
http://dx.doi.org/10.3390/pharmaceutics12090859
work_keys_str_mv AT viganibarbara recentadvancesinthedevelopmentofinsitugellingdrugdeliverysystemsfornonparenteraladministrationroutes
AT rossisilvia recentadvancesinthedevelopmentofinsitugellingdrugdeliverysystemsfornonparenteraladministrationroutes
AT sandrigiuseppina recentadvancesinthedevelopmentofinsitugellingdrugdeliverysystemsfornonparenteraladministrationroutes
AT bonferonimariacristina recentadvancesinthedevelopmentofinsitugellingdrugdeliverysystemsfornonparenteraladministrationroutes
AT caramellacarlam recentadvancesinthedevelopmentofinsitugellingdrugdeliverysystemsfornonparenteraladministrationroutes
AT ferrarifranca recentadvancesinthedevelopmentofinsitugellingdrugdeliverysystemsfornonparenteraladministrationroutes